| Valerie Lynn Height, LCSW, LMHP | |
|
12717 S 28th Ave, Bellevue, NE 68123-3232 | |
| (402) 292-6006 | |
| Not Available |
| Full Name | Valerie Lynn Height |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 10 Years |
| Location | 12717 S 28th Ave, Bellevue, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548856750 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 5266 (Nebraska) | Secondary |
| 1041C0700X | Social Worker - Clinical | 1812 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bellevue Primary Healthcare Pc | 2860639051 | 7 |
News Archive
Molecular dermatology research and development innovator HairDX today announced the results of a six month pilot study that presents, for the first time, evidence that genetic mechanisms may predict treatment response to Finasteride for postmenopausal female Androgenetic Alopecia (female hair loss).
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that it closed a €100 million placement of Preferred Stock to a group of investors.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant at CGD, note that while the decreases in funding for the Global Health Initiative (GHI) and PEPFAR in President Obama's FY 2013 budget request are "alarming," the "bright spot" is that multilateral programs, including the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, would get increases in their funding.
The Prostate Cancer Foundation and Major League Baseball are once again stepping up to the plate to hit home runs for prostate cancer research and encourage fans to "Keep Dad in the Game" as part of the 20th Annual Home Run Challenge. This hallmark event will take place during the six days leading up to Fathers' Day and will help raise crucial awareness and much needed research funding for prostate cancer.
› Verified 7 days ago
| Entity Name | Bellevue Primary Healthcare Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497091888 PECOS PAC ID: 2860639051 Enrollment ID: O20130507000450 |
News Archive
Molecular dermatology research and development innovator HairDX today announced the results of a six month pilot study that presents, for the first time, evidence that genetic mechanisms may predict treatment response to Finasteride for postmenopausal female Androgenetic Alopecia (female hair loss).
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that it closed a €100 million placement of Preferred Stock to a group of investors.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant at CGD, note that while the decreases in funding for the Global Health Initiative (GHI) and PEPFAR in President Obama's FY 2013 budget request are "alarming," the "bright spot" is that multilateral programs, including the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, would get increases in their funding.
The Prostate Cancer Foundation and Major League Baseball are once again stepping up to the plate to hit home runs for prostate cancer research and encourage fans to "Keep Dad in the Game" as part of the 20th Annual Home Run Challenge. This hallmark event will take place during the six days leading up to Fathers' Day and will help raise crucial awareness and much needed research funding for prostate cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Valerie Lynn Height, LCSW, LMHP 2507 Hogantown Dr, Bellevue, NE 68123-6094 Ph: (402) 885-1262 | Valerie Lynn Height, LCSW, LMHP 12717 S 28th Ave, Bellevue, NE 68123-3232 Ph: (402) 292-6006 |
News Archive
Molecular dermatology research and development innovator HairDX today announced the results of a six month pilot study that presents, for the first time, evidence that genetic mechanisms may predict treatment response to Finasteride for postmenopausal female Androgenetic Alopecia (female hair loss).
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that it closed a €100 million placement of Preferred Stock to a group of investors.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant at CGD, note that while the decreases in funding for the Global Health Initiative (GHI) and PEPFAR in President Obama's FY 2013 budget request are "alarming," the "bright spot" is that multilateral programs, including the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, would get increases in their funding.
The Prostate Cancer Foundation and Major League Baseball are once again stepping up to the plate to hit home runs for prostate cancer research and encourage fans to "Keep Dad in the Game" as part of the 20th Annual Home Run Challenge. This hallmark event will take place during the six days leading up to Fathers' Day and will help raise crucial awareness and much needed research funding for prostate cancer.
› Verified 7 days ago